Viewing Study NCT04857359


Ignite Creation Date: 2025-12-24 @ 2:45 PM
Ignite Modification Date: 2025-12-25 @ 4:13 PM
Study NCT ID: NCT04857359
Status: TERMINATED
Last Update Posted: 2025-08-06
First Post: 2021-04-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy
Sponsor: Addex Pharma S.A.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module